JP2006241031A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006241031A5 JP2006241031A5 JP2005056733A JP2005056733A JP2006241031A5 JP 2006241031 A5 JP2006241031 A5 JP 2006241031A5 JP 2005056733 A JP2005056733 A JP 2005056733A JP 2005056733 A JP2005056733 A JP 2005056733A JP 2006241031 A5 JP2006241031 A5 JP 2006241031A5
- Authority
- JP
- Japan
- Prior art keywords
- skin
- viscosity
- external preparation
- dosage form
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003491 Skin Anatomy 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 9
- DQAKJEWZWDQURW-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 claims description 7
- 229940079889 Pyrrolidonecarboxylic Acid Drugs 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 229940113118 Carrageenan Drugs 0.000 claims description 5
- 239000000679 carrageenan Substances 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229920001888 polyacrylic acid Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Description
化粧料などの皮膚外用剤において、粘度が10000mPascal・秒以上と高粘度のエッセンス剤形は、投与すべき部位に的確に、広がらずに皮膚外用剤を投与できるため、極めて有用な剤形であると言える。これは、医薬部外品のような、化粧料の中でも、効能・効果がより明瞭である種別においては、より顕著であると言える。かかるエッセンス剤形の皮膚外用剤において、特に大きな課題となることは、経時的な粘度低下であると言える。特に、ピロリドンカルボン酸或いは、その塩の存在下においては、カルボキシビニルポリマーなどの増粘剤は、架橋構造を形成しにくい為、前記の粘度を安定に維持しつつ、これらの成分の安定性も維持することは非常に困難であった。前記ピロリドンカルボン酸或いはその塩は皮膚との馴染みが良く、且つ、優れた保水特性を有するために広く化粧良品分野で、保湿成分として使用されている(例えば、特許文献1、特許文献2を参照)が、この様な欠点故にその配合できる剤形は極めて限られたものとなっている(例えば、特許文献3、特許文献4を参照)。 In the external preparation for skin such as cosmetics, essence dosage form of a high viscosity and viscosity 10000MPascal · sec or more, precisely at the site to be administered, it is possible to administer the external preparation for skin in reluctant wide, with very useful dosage form It can be said that there is. This can be said to be more remarkable in types of cosmetics such as quasi-drugs that have clearer efficacy and effects. In such an essence dosage form, it can be said that a particularly big problem is a decrease in viscosity over time. In particular, in the presence of pyrrolidone carboxylic acid or a salt thereof, a thickener such as carboxyvinyl polymer is difficult to form a crosslinked structure, so that the stability of these components is maintained while maintaining the above-mentioned viscosity stably. It was very difficult to maintain. The pyrrolidone carboxylic acid or a salt thereof has good compatibility with the skin, and, in a wide decorative good areas in order to have a good water retention properties, that has been used as a moisturizer (e.g., see Patent Document 1, Patent Document 2 ) is such disadvantage because the formulation may dosage form that has become what was very limited (e.g., see Patent Document 3, Patent Document 4).
一方、カラギーナンはゲル化・増粘剤として、化粧料などの皮膚外用剤の分野や、食品の分野で使用されている原料であるが、かかる成分とピロリドンカルボン酸を概念上組み合わせることは開示されている(例えば、特許文献5、特許文献6を参照)が、実際に組み合わせて含有させた例はなく、その粘度安定化効果は全く知られていなかった。 On the other hand, carrageenan is a raw material used as a gelling / thickening agent in the field of external preparations for skin, such as cosmetics, and in the field of food. However, it is disclosed that these components and pyrrolidonecarboxylic acid are conceptually combined. Tei Ru (e.g., Patent Document 5, refer to Patent Document 6) is not actually a combination example which contains, in its viscosity stabilizing effect was not known.
この様な状況に鑑みて、本発明者らは、ピロリドンカルボン酸及び/又はその塩を含有しつつも、粘度安定性に優れるエッセンス剤形の皮膚外用剤を求めて、鋭意研究努力を重ねた結果、1)カラギーナン0.5〜2質量%と、2)ピロリドンカルボン酸及び/又はその塩0.1〜10質量%とを含有する皮膚外用剤がその様な特性を備えていることを見出し、発明を完成させるに至った。即ち、本発明は以下に示すとおりである。
(1)1)カラギーナン0.5〜2質量%と、2)ピロリドンカルボン酸及び/又はその塩0.1〜10質量%とを含有し、粘度が10000mPascal・秒以上であることを特徴とする、エッセンス剤形の皮膚外用剤。
(2)pHが7以下であることを特徴とする、(1)に記載の皮膚外用剤。
(3)化粧料である、(1)又は(2)に記載の皮膚外用剤。
In view of such a situation, the present inventors have intensively researched and sought for an external preparation for essence dosage form having excellent viscosity stability while containing pyrrolidonecarboxylic acid and / or a salt thereof. As a result, it was found that a skin external preparation containing 1) carrageenan 0.5 to 2% by mass and 2) 0.1 to 10% by mass of pyrrolidonecarboxylic acid and / or a salt thereof has such characteristics. The present invention has been completed. That is, the present invention is as follows.
(1) 1) It contains 0.5 to 2% by mass of carrageenan, 2) 0.1 to 10% by mass of pyrrolidonecarboxylic acid and / or its salt, and has a viscosity of 10,000 mPascal · second or more. , Skin preparation for essence dosage form
(2) The external preparation for skin according to (1), wherein the pH is 7 or less.
(3) The external preparation for skin according to (1) or (2) , which is a cosmetic .
(4)本発明の皮膚外用剤
本発明の皮膚外用剤は、前記必須成分を含有することを特徴とする。本発明の皮膚外用剤としては、皮膚に外用で投与されるものであれば特段の限定無く適用でき、例えば、化粧料(医薬部外品を含む)、皮膚外用医薬組成物、雑貨などが例示でき、これらの内では化粧料が特に好ましい。皮膚外用剤の剤形としては、粘度が10000mPascal・秒以上である高粘剤形、すなわち通常エッセンス剤形と言われている剤形が挙げられる。この様な剤形を取ることにより、有効成分の効果が必要な局所部位に的確に投与でき、且つ、投与範囲を限局することが出来るためである。又、この時pHは皮膚のそれに近い7以下であることが好ましい。
(4) External preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing the essential components. The topical skin preparation of the present invention can be applied without particular limitation as long as it is externally administered to the skin. Examples thereof include cosmetics (including quasi-drugs), pharmaceutical compositions for external use on skin, and miscellaneous goods. Of these, cosmetics are particularly preferred. The dosage form of the external preparation for skin, the viscosity is highly viscous dosage form is at least 10000MPascal · sec, ie include dosage forms are said to normally essence dosage form. This is because by taking such a dosage form, it is possible to accurately administer the active ingredient to a local site where the effect of the active ingredient is necessary, and to limit the administration range. At this time, the pH is preferably 7 or less which is close to that of the skin.
以下に示す処方に従って、本発明の皮膚外用剤である、化粧料を作成した。即ち、イ、ロの成分をそれぞれ80℃に加熱し、良く混合した後、攪拌下、ロに徐々にイを加え、しかる後、攪拌冷却し、エッセンス剤形(粘度:27000mPascal・秒;B型粘度計4号ローター、20℃、pH6.55)の化粧料1を得た。このものの、カラギーナンを、アラビアガムに置換した比較例1(粘度:26500mPascal・秒、pH6.45)、20%カルボキシビニルポリマー(添加後10%水酸化カリウム水溶液1mlを加え中和)に置換した比較例2(粘度23500mPascal・秒、pH8.45)、キサンタンガムに置換した比較例3(粘度21000mPascal・秒。pH6.65)も同様に作成した。 In accordance with the formulation shown below, a cosmetic, which is an external preparation for skin of the present invention, was prepared. That is, the components of A and B are heated to 80 ° C. and mixed well, and then gradually added to B under stirring, and then cooled with stirring to obtain an essence dosage form (viscosity: 27000 mPascal · second; B type). Viscometer No. 4 rotor, 20 ° C., pH 6.55) cosmetic 1 was obtained. In this, Carrageenan was replaced with Comparative Example 1 (viscosity: 26500 mPascal · sec, pH 6.45) substituted with gum arabic, 20% carboxyvinyl polymer (neutralized by adding 1 ml of 10% aqueous potassium hydroxide solution after addition). Example 2 (viscosity 23500 mPascal · second, pH 8.45) and Comparative Example 3 (viscosity 21000 mPascal · second, pH 6.65) substituted with xanthan gum were also prepared in the same manner.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005056733A JP4801361B2 (en) | 2005-03-02 | 2005-03-02 | Essence dosage form topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005056733A JP4801361B2 (en) | 2005-03-02 | 2005-03-02 | Essence dosage form topical skin preparation |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2006241031A JP2006241031A (en) | 2006-09-14 |
JP2006241031A5 true JP2006241031A5 (en) | 2008-05-01 |
JP4801361B2 JP4801361B2 (en) | 2011-10-26 |
Family
ID=37047800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005056733A Expired - Fee Related JP4801361B2 (en) | 2005-03-02 | 2005-03-02 | Essence dosage form topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4801361B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6005967B2 (en) * | 2012-03-29 | 2016-10-12 | 株式会社コーセー | UV protection cosmetics |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3563815B2 (en) * | 1995-03-07 | 2004-09-08 | 株式会社ノエビア | Solid oil-in-water emulsified cosmetic |
JP3484361B2 (en) * | 1998-11-02 | 2004-01-06 | 花王株式会社 | Skin cosmetics |
JP3531734B2 (en) * | 2000-01-11 | 2004-05-31 | 株式会社資生堂 | Skin whitening external preparation |
JP2001233755A (en) * | 2000-02-25 | 2001-08-28 | Yakult Honsha Co Ltd | Skin care preparation composition |
JP2002173413A (en) * | 2000-12-05 | 2002-06-21 | Api Co Ltd | Cosmetic |
JP2003267855A (en) * | 2002-03-15 | 2003-09-25 | Kose Corp | Cosmetic |
-
2005
- 2005-03-02 JP JP2005056733A patent/JP4801361B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20190060649A (en) | An aqueous solution for solubilizing salicylic acid, a process thereof, and a cosmetic composition comprising them | |
JP6207291B2 (en) | Composition for external use | |
JP2020529971A (en) | Nanoscale sulfur-containing compositions and their applications | |
TWI761672B (en) | Compositions of o-glycosyl flavonoids | |
JP2019116510A (en) | Oral composition | |
WO2014073490A1 (en) | Oral composition | |
WO2014157547A1 (en) | Composition for oral cavity | |
JP4959006B2 (en) | Hesperidin-containing composition | |
JP2014162725A (en) | External composition | |
EP2654699B1 (en) | Active ingredient combinations of glyceryl glucosides and one or more preservatives | |
CN107787218A (en) | liquid cooling composition | |
JP2011093835A (en) | Skin care preparation | |
JPH07233045A (en) | Skin external preparation | |
EP1293194A1 (en) | Physically stable sprayable gel composition | |
JP6515198B2 (en) | High molecular | |
JP2006241031A5 (en) | ||
JP6221536B2 (en) | Composition for external use | |
JP2012240966A (en) | Organic-inorganic composite thickened body and method for preparing the same, and gel cosmetic or substrate for external preparation | |
JPH0372202B2 (en) | ||
JP2003238381A (en) | Cosmetic composition | |
JP3969587B2 (en) | Azulene sulfonate sodium preparation | |
KR102213669B1 (en) | Solubilized composition of caffeine | |
WO2016104695A1 (en) | Cosmetic composition containing acyl basic amino acid derivative and anionic water-soluble polymer | |
JP7398274B2 (en) | External composition | |
JP6634703B2 (en) | External composition |